Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
NeuroBo Pharmaceuticals ( (NRBO) ) just unveiled an update.
NeuroBo Pharmaceuticals is set to rebrand as MetaVia Inc. on November 29, 2024, with a new Nasdaq ticker symbol, MTVA, reflecting its focus on cardiometabolic diseases. This strategic realignment accompanies significant clinical milestones, including trials for DA-1241 and DA-1726, targeting conditions like obesity and MASH. Despite the name change, shareholders’ rights remain unaffected, and operations continue as usual, supported by a strong financing background.
Learn more about NRBO stock on TipRanks’ Stock Analysis page.
